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ABSTRACT - Purpose. Many chemical 
compounds and infectious agents such as viruses 
induce liver damage like necrosis or fulminant 
hepatic failure which is sometimes difficult to 
manage by medical therapies. The induced liver 
necrosis by carbon tetrachloride (CCl4) and 
thioacetamide (TAA) are exemplary models for 
experimental liver necrosis caused by oxygen free 
radicals. The aim of this study was to investigate 
the effects of tungstophosphoric acid (TPA) and 
sodium tungstate (ST) on liver injury induced by 
CCl4 or TAA. Methods. Hepatoprotective effects of 
TPA and ST on acute liver necrosis, chemically 
induced, were evaluated by the activity of serum 
enzymes (alkaline phosphatase, alanine 
transaminase and aspartate transaminase), oxidative 
stress parameters (activity of xanthine oxidase, 
concentrations of malondialdehyde and production 
of superoxide anion), antioxidative defence markers 
(concentration of reduced glutathione), and 
histopathology in Wistar rats. Liver necrosis was 
induced by administering a single intraperitoneal 
(i.p.) injection of CCl4 (1.0 ml/kg b.wt. of 80% 
CCl4 in corn oil) or a single i.p. injection of TAA 
(400 mg/kg b.w. dissolved in normal saline). TPA 
and ST were administrated to rats orally for 7 
weeks (50 mg/kg b.wt.) prior to induction of liver 
necrosis.  Results. Induced liver necrosis caused 
significant elevation of activity of liver enzymes, 
parameters of oxidative stress and marked changes 
in histopathology, like necrosis of hepatocytes, 
hepatocyte degeneration and infiltration of 
inflammatory cells. In TPA and ST pretreated rats 
histopathological changes were almost absent, 
serum enzymes and oxidative stress parameters 
were decreased, while at the same time the 
concentration of reduced gluthathione was 
increased.  Conclusion. The present findings 
suggest that treatment with TPA and ST for 7 
weeks could be useful for the prevention of hepatic 
injury in rats. 
 
INTRODUCTION 
 
Acute hepatic failure and liver necrosis frequently 
develops upon exposure of the tissue to viruses or 
numerous chemical agents and represents a 
complex process, characterized by simultaneous 
activation of multiple deregulated pathways that 
culminate in the loss of cell membrane integrity and 
thus, the leakage of cellular constituents (1). The 
understanding and treatment of liver necrosis has 
developed rapidly over the last 50 years. Using 
animal models that reflect the clinical, biochemical 
and histological pattern of the syndrome seen in 
humans  progress has been made in reducing 
morbidity and mortality from this syndrome. 
Administration of two hepatotoxins, carbon 
tetrachloride (CCl4) and thioacetamide (TAA) is 
often used to induce experimental acute liver 
necrosis in rats. Previous studies have shown that 
the hepatotoxic effects of CCl4 and TAA involve 
oxidative stress manifested as a lipid peroxidation, 
protein oxidation and alterations in tissue 
antioxidants (2-5).  
During the last decades, studies of 
biomedical activity of inorganic compounds like 
molybdenum and vanadium compounds have 
attracted the attention of numerous investigators (6-
9). Reviews about bioactivity of tungsten 
compounds are infrequent (10-12). Tungstate shares 
a common tetrahedral structure (13) with vanadate, 
molybdate and phosphate, and this structure seems 
to be an important characteristic of efficient 
inhibitors competing with 
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phosphate substrates for binding to the active 
catalytic site of phosphatases. The literature data 
confirmed that only oxoanionic molecular species 
of tungsten W (VI) (such as WO4
2- in sodium 
tungstate
 Na2WO4, ST) are stable under the aqueous 
conditions (6,7). Tungsten has the ability to form 
weak acids, readily condensing/polymerizing into 
anions containing several molecules of an acid 
anhydride. When these condensed species contain 
only one type of acid anhydride, they form isopoly 
compounds. Condensation of the acid with other 
acids (e.g., phosphoric or silicic), leads to the 
formation of the ‘polyoxotungstate’, such as Keggin 
anion, [PW12O40]
3-,  in 12-tungstophosphoric acid 
(TPA). Polyoxotungstates such as TPA are well-
known in several application fields, such as 
analytical reagents, catalysis, nanomaterials, etc., 
but biomedical activities of TPA are still not well 
defined.  
Much attention has recently been given to 
ST as a potential compound with biochemical and 
biological effects based mainly on binding affinity 
with many substances (14-18). Sodium tungstate 
therapy is already known and utilized as a non-
traditional folk medicine in Japan. Recent studies 
(19-21) reported antidiabetic and antiobesity 
properties of ST. Pawa and Ali (22) pointed to the 
protective role of the ST in liver necrosis and 
fulminant hepatic failure in rats.  
The aim of this study was to investigate 
protective effects of TPA on induced liver necrosis 
in adult Wistar rats. In assessing the protective 
effect of TPA on liver necrosis, we also used ST, 
which was previously confirmed as a 
hepatoprotective agent. To our knowledge it is for 
the first time that hepatoprotective effect of 
tungstophosphoric acid has been tested.   
 
MATERIALS AND METHODS 
 
Animals 
 
Eight weeks old female albino rats of the Wistar 
strain (weighing 150-180 g) were provided from the 
Military Medical Academy Animal House, 
Belgrade. The animals were maintained with 
commercial rat feed and water available ad libitum. 
They were housed in polypropylene cages at room 
temperature 25±2
°C (each group contained ten rats) 
with a wire mesh top and a hygienic bed of soft 
wood scrapings with proper humane care. Animal 
studies were conducted in accordance with the 
institutional guidelines for care and use of 
laboratory animals.  
The animals were divided into nine groups, 
each of which contained 10 rats. Group 1 was the 
normal control group (N) in which saline solution 
and corn oil were given orally. Groups 2 and 3 were 
rats orally treated with sodium tungstate and 
tungstophosphoric acid (ST, TPA, respectively). 
Groups 4 and 5 were the CCl4- and TAA-induced 
liver necrosis groups (C,T, respectively) in which 
liver necrosis was induced with a single 
intraperitoneal injection of hepatotoxin. Groups 6-9 
were rats orally treated with sodium tungstate and 
tungstophosphoric acid prior to induction of liver 
necrosis by CCl4 and TAA (ST+C, ST+T, TPA+C, 
TPA+T, respectively).   
 
Chemicals 
 
Chemicals used in this study were of the highest 
purity. TPA and ST were purchased from Aldrich 
Chemical Company, Milwaukee, USA. TPA was 
previously recrystallized twice from bidistilled 
water. All other chemicals and solvents were of 
commercial p.a. reagent-grade and were used 
without further purification.  
 
Induction of liver necrosis  
 
Liver necrosis was induced by administering a 
single intraperitoneal (i.p.) injection of CCl4 (1.0 
ml/kg b.wt. of 80% CCl4 in corn oil) or a single i.p. 
injection of TAA (400 mg/kg b.w. dissolved in 
normal saline).  
To evaluate and compare the protective 
roles of TPA and ST against hepatic lesions 
produced by TAA and CCl4, they were 
administrated to rats orally for 7 weeks (50 mg/kg 
b.wt.) followed by necrogenic dose of each 
hepatotoxin. 
 
Processing of the liver tissue and biochemical 
estimations 
 
Liver injury was evaluated by analyzing 
serum/tissue lysate obtained from rats sacrificed 
24h after receiving the necrogenic dose of 
hepatotoxins. Rats were anesthetized with ether and 
the blood was drawn by puncture from vena cava 
inferior. Blood was allowed to clot and the serum J Pharm Pharmaceut Sci (www. cspsCanada.org) 10 (3): 340-349, 2007 
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was separated by centrifugation at 1200 x g for 10 
min. Serum was used to analyze activity of liver 
enzymes alkaline phosphatase and transaminases. 
Other biochemical estimations were performed on a 
tissue homogenate prepared from the liver. 
Each animal was weighed before 
sacrificing. Total liver weight of rats from each 
group was also recorded before the tissue was 
processed for analyses. The livers of the rats were 
removed, washed in ice-cold saline solution, blotted 
and a small portion was cut and weighed for 
homogenization. Tissue lisate was prepared in nine 
volumes of 0.1 M phosphate buffer (pH 7.4) 
containing 1.15% KCl, using a homogenizer. A 
portion of the homogenate was kept for 
determination of hepatic malondialdehyde, 
superoxide anion and reduced glutathione content. 
The rest of the homogenate was subjected to 
centrifugation in a cooling centrifuge initially at 
800 x g for 10 min (to remove the nuclei and other 
cell debris) and then the resultant supernatant was 
centrifuged at 9500 x g for 20 min to get the post-
mitochondrial supernatant (used to measure activity 
of xanthine oxidase). 
Activities of alanine transaminase (ALT) 
and aspartate trasaminase (AST) and alkaline 
phosphatase (AP) were measured using diagnostic 
kits (Randox Laboratories, UK), and enzyme 
activity was expressed in U/L.  
To determine the index of oxidative stress 
in the liver tissue, we used the thiobarbituric acid 
reacting substances (TBARs) test that measures the 
quantity of the malondialdehyde (MDA) product as 
by Girotti et al (23). MDA concentration is 
expressed as nmol/g of liver protein. Production of 
superoxide anion (O2
.-) as a marker of the first stage 
of oxidative stress was measured as described by 
Auclair and Voisin (24) at pH 7 and 25°C from the 
rate of nitroblue tetrazolium (NBT) reduction. 
Results are expressed as nmol NBT/min/g of liver 
protein. Reduced glutathione (GSH) content was 
measured according to method of Jollow et al. (25). 
Results are expressed as nmol GSH/g of liver 
protein. Xanthine oxidase (XO) in 
postmitochondrial supernatant (PMS) was assayed 
according to Stirpe-Della Corte method (26). 
Results are expressed as mmol uric acid/g of PMS 
protein. 
  The total protein concentration in all tissue 
samples was assayed according to Bradford’s 
method (27).  
Histopathology 
 
Hepatic morphology was assessed by light 
microscopy. The left lateral lobe of the liver was 
sliced (three slices per rat) fixed in 10 % buffered-
neutral formalin and embedded in paraffin. 
Transverse sections of 5 μm in thickness were 
subjected to hematoxylin and eosin (H&E) staining 
before examinations (28). The sections were 
scanned and analyzed by a certified pathologist who 
was not aware of sample assignment to 
experimental groups. A minimum of 10 fields was 
scored per liver slice to obtain the mean value. To 
quantify the morphological changes, liver sections 
were graded for necrosis using an arbitrary scale: 0-
negative findings (0 %); 1-slight (about 20-30 % 
necrosis); 2-moderate (about 50 % necrosis); 3-
marked (about 75 % necrosis); and 4-very intense 
(about 90-100 % necrosis) (29). 
 
 Statistical analysis 
 
All data were expressed as mean ± standard error of 
mean (S.E.M). Differences between the hepatotoxin 
treated group and tungstate-pretreated groups were 
assessed by the Mann-Whitney U-test. P < 0.05 was 
considered to be significant. 
 
RESULTS 
 
Effects of tungstophosphoric acid and sodium 
tungstate on liver histology and liver weight/body 
weight ratio 
 
The effects of TPA and ST on the acute liver 
necrosis induced by CCl4 or TAA were assessed by 
histopathological examinations. The hematoxylin 
and eosin staining of liver specimens is 
demonstrated in Figure 1. 
  There are no pathological changes in 
healthy control livers which showed normal lobular 
architecture with central vein and radiating hepatic 
cords (Figure 1a). Rats treated with tungstate alone 
showed no sign of damage (Figure 1 d,g) when 
compared to the normal control. Hepatic cell death 
induced by the specified doses of CCl4 or TAA is 
observed to be restricted to necrosis. 
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Figure 1. The representative hepatic histopathology: a) Normal liver from normal (healthy) untreated control 
rat. b) Severe centrilobular necrosis and infiltration in rats treated with CCl4 . c) Necrosis and  mononuclear cell 
infiltration in rats treated with TAA. d) Rats pretreated with TPA alone. Normal appearance of liver. e) Rats 
pretreated with TPA followed by CCl4. Normal appearance of liver. f) Rats pretreated with TPA followed by 
TAA. Normal appearance of liver. g) Rats treated with ST alone. Normal appearance of liver. h) Rats pretreated 
with ST followed by CCl4. Normal appearance of liver. i) Rats pretreated with ST followed by TAA. Normal 
appearance of liver. Hematoxylin and eosin (H&E) staining (200x). 
 
Apoptotic bodies were not detected in any of the 
slides. In CCl4 treated rats, sections show necrosis 
of hepatocytes, hepatocyte degeneration and 
infiltration of inflammatory cells. There was 
marked neutrophilic and mononuclear cell 
infiltration with severe centrilobular congestion 
(Figure 1 b). Bridging necrosis was present in 
certain cases. Changes improved in TPA pretreated 
rats, which exhibited areas of normal liver 
architecture and patches of necrotic hepatocytes 
(Figure 1 e). The liver section of TAA treated rats 
also shows necrosis of hepatocytes with liver 
architecture destruction, and inflammatory infiltrate 
in the portal tracts (Figure 1 c). These changes were 
almost absent (except for a few necrotic areas) in 
sections of liver obtained from rats receiving TPA 
and ST followed by TAA (Figure 1 f,i).  
  The liver weight/body weight ratio is 
presented in Table 1 in experimental groups. Only 
in ST treated rats was the liver weight/body weight 
ratio lower than for the normal control.  
Effects of tungstophosphoric acid and sodium 
tungstate on biochemical parameters associated 
with liver necrosis 
 
The serum activities of ALT, AST and AP were 
used as biochemical markers for the early acute 
hepatic damage. In TPA and ST treated rats the 
activity of these parameters was not different 
comparing with normal untreated rats (N). Necrosis 
score (NS) and activity of liver enzymes in CCl4 
and TAA treated rats were significantly higher than 
in normal control (Figure 2 a,b,c,d). In rats 
pretreatred with tungsten compounds followed by 
hepatotoxins (TPA+C, ST+C, TPA+T) liver 
enzymes and necrosis score significantly decreased. 
In ST+T group activity of liver enzymes and 
necrosis score showed a trend to decreasing (not 
statistically significant) when compared with T 
group.J Pharm Pharmaceut Sci (www. cspsCanada.org) 10 (3): 340-349, 2007 
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Table 1. Liver weight/body weight ratios in rats 
 
Experimental 
groups
* 
Liver weight / 
body weight (means 
± S.E.M) 
N  3.73 ± 0.32 
C  3.62 ± 0.17 
T  3.38 ± 0.15 
TPA  3.33 ± 0.15 
ST  2.88 ± 0.06
** 
TPA+C  3.35 ± 0.26 
TPA+T  3.29 ± 0.08 
ST+C  3.82 ± 0.14 
ST+T  3.63 ± 0.22 
 
* N: normal control, rats without any treatment; C,T: 
CCl4- and TAA-induced liver necrosis rats; TPA, 
ST: rats orally treated with tungstophosphoric acid  
and sodium tungstate; TPA+C, TPA+T, ST+C, 
ST+T: rats orally treated with tungstophosphoric 
acid and sodium tungstate prior to induction of liver 
necrosis by CCl4 and TAA respectively.   
** significantly different from normal control, 
P<0.05.   
 
 
In TPA- and ST-treated rats, the activity of 
XO was not different comparing to the normal-
untreated rats (Figure 3 a). Levels of XO in CCl4 
treated rats were significantly higher than in the 
normal control. In TAA treated rats, XO was 
slightly elevated. Activity of XO in TPA and ST 
pretreated rats followed by CCl4 induced necrosis, 
and TPA pretreated rats followed by TAA induced 
necrosis, were significantly lower than in rats with 
liver necrosis.  
Both the hepatotoxin treated groups (Figure 
3 b,c) showed elevation of oxidative stress 
parameters, O2
.¯and MDA comparing to normal, 
untreated rats. Significant decrease of O2
·¯ was 
detected in TPA and ST pretreated groups followed 
by TAA induced liver necrosis. But, in tungsten 
compounds pretreated groups followed by CCl4 
induced liver necrosis there was a tendency to 
decreasing production of O2
·¯. The concentration of 
MDA in all pretreated groups followed by both 
hepatotoxins showed tendency to decreasing, but 
not statistically significant. 
Significant depletion of reduced glutathione 
(GSH) was detected in CCl4 and TAA treated rats 
(Figure 3 c). Pretreatment with TPA or ST leads to 
significant rise in hepatic GSH level. Increasing of 
the GSH in CCl4 induced necrosis was more 
efficient by ST pretreatment than by TPA 
pretreatment. However, in TAA induced liver 
necrosis, TPA pretreatment was more efficient in 
elevation of GSH.  
 
DISCUSSION 
 
A number of drugs, chemicals and viruses have 
been reported to cause severe liver necrosis, which 
sometimes becomes difficult to manage by medical 
therapies. It is important to search for compounds 
that can be used for better management of the 
hepatic failure due to severe necrosis.  
  The present study was designed to evaluate 
whether pretreatment with different compounds of 
tungsten (TPA and ST) would have a 
hepatoprotective effect on chemically induced liver 
necrosis. It has been already reported that ST could 
protect progression of CCl4 and TAA induced 
hepatic injury (22).  However, the in vivo 
hepatoprotective activity of TPA remains unknown.  
Rats orally treated with TPA as well as ST 
(50 mg/kg b.wt.) during the 7 weeks did not have 
changes of liver enzymes and hepatic histology 
(Figure 1 d,g) when compared to the normal control 
(Figure 1 a). But we   detected decreasing of liver 
weight/body weight ratio in ST treated rats 
compared to untreated rats (Table 1).   
In this study, to induce liver damage, we 
used compounds which mediate their hepatotoxicity 
via the formation of free radicals, especially the 
reactive oxygen species (ROS). CCl4 and TAA 
induced toxicity as experimental models are well-
characterized (2, 4). The hepatotoxicity of both 
compounds results from their metabolism by the 
cytochrome P450 enzyme system into the reactive 
intermediates, which leads to oxidative stress and 
causes hepatic necrosis. The necrogenic doses of 
CCl4 and TAA which have been given to rats 
significantly elevated necrosis score and liver 
enzymes (Figure 2 a,b,c,d). These results were 
consistent with the literature (2,5). Also, this study 
has shown that prophylactic treatment of rats with 
TPA and with ST, before the induction of liver 
injury, effectively alleviates the liver injury as 
indicated by significant decrease necrosis score and 
liver enzymes (Figure 2 a,b,c,d). J Pharm Pharmaceut Sci (www. cspsCanada.org) 10 (3): 340-349, 2007 
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Figure 2. Effects of TPA and ST on biochemical parameters associated with liver necrosis. Data are expressed 
as means ± S.E.M. (n=10). ST and TPA-pretreated groups were compared with hepatotoxin treated group. The 
level of statistical significance was:*P<0.05 and ** P<0.001. a) necrosis score (%); b) activity of alkaline 
phosphatase (U/L); c) activity of aspartate transaminase (U/L); d) activity of alanine transaminase (U/L). J Pharm Pharmaceut Sci (www. cspsCanada.org) 10 (3): 340-349, 2007 
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Effects of tungstophosphoric acid and sodium tungstate on biochemical parameters associated with liver 
necrosis as a result of oxidative stress 
 
The results of oxidative stress parameters and antioxidative defence in the liver in rats are shown in Figure 3 
a,b,c,d.  
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Figure 3. Effects of TPA and ST on oxidative stress parameters and antioxidative defence status Data are 
expressed as means ± S.E.M (n=10). ST and TPA-pretreated groups were compared with hepatotoxin-treated 
group. The level of statistical significance was: *P<0.05 and ** P<0.001. a) activity of xanthine oxidase 
(mmol/g protein); b) production of superoxide anion (nmol/min/g protein); c) malondialdehyde (nmol/g 
protein.); d) reduced glutathione (nmol/g protein). J Pharm Pharmaceut Sci (www. cspsCanada.org) 10 (3): 340-349, 2007 
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Histopathological data also pointed towards 
beneficial effects of TPA and ST in ameliorating 
liver damage induced by CCl4 and TAA (Figure1). 
In CCl4 induced hepatic injury ST was more 
efficient in hepatoprotection than TPA, while in 
TAA induced hepatic injury, TPA was more 
efficient than ST.  
The involvement of xanthine oxidase in 
ROS-mediated diseases has been proposed as a 
result of the generation of O2
.¯  and H2O2 during 
hypoxanthine and xanthine oxidation. Xanthine 
oxydoreductase is molybdenum-containing 
monooxygenase and exists as dehydrogenase 
(XDH) and oxidase (XO). The XDH prefers NAD
+ 
as an electron acceptor, but will use molecular 
oxygen in the absence of NAD
+. The XO utilizes
 
oxygen as an electron acceptor and has very little 
activity toward NAD
+ which promotes generation 
of ROS. Under physiological conditions, the 
enzyme is active as  XDH, but several stimuli such 
as inflammation and hypoxia promote the 
conversion of XDH to the XO form. Moreover, it 
was shown (30) that, in pathological conditions, 
H2O2 derived from the NADPH oxidase markedly 
enhances the irreversible conversion of XDH to 
XO, leading to ROS production.  
To evaluate the involvement of oxygen 
radicals in hepatic damage and potential defence of 
tungsten compounds, we have measured activity of 
XO. In this study we have found that CCl4 and 
TAA induced necrosis provokes XO activity which 
produces oxidative stress by generating ROS 
(Figure 3a), indicating its role in this type of liver 
injury. Significant decrease of XO activity was 
observed in ST pretreated rats followed by 
hepatotoxins (Figure 3a), which is in accordance 
with results of Pawa and Ali (22). Recent studies 
reported that ST prevents molybdenum 
incorporation into the active centre of XDH/XO as 
a competitive inhibitor and provokes decrease of 
XO activity (31-32). Further, we detected decrease 
of XO activity in TPA treated rats, which could 
explain the hepatoprotective effect of TPA by the 
same mechanism as in ST pretreatment. 
Superoxide anion radical O2
.¯ is produced 
in aerobic metabolism, and imbalance between the 
production and detoxification results in oxidative 
stress. O2
.¯ reacts with polyunsaturated fatty acids to 
induce the release of toxic and reactive aldehyde 
metabolites such as malondialdehyde, one of the 
end products of lipid peroxidation. As a result of 
increased activity of XO and the activity of the 
other ROS-generating sources, we obtained 
increased production of O2
.¯ in hepatotoxin treated 
groups compared with normal control. Suppression 
of XO activity by both tungsten compounds 
followed by TAA induced necrosis resulted in 
decrease of O2
.¯  production (Figure 3 b). 
Pretreatment with TPA or with ST in CCl4 induced 
necrosis showed tendency to reduce production of 
O2
.¯ but not significantly (Figure 3 b).  
Increase in hepatic MDA concentration was 
detected, as an index of oxidative liver damage, in 
CCl4 and TAA treated rats (Figure 3 c), which 
supports the role of XO-derived ROS in their 
hepatotoxicity. We observed reduction of MDA 
concentration by both tungsten compounds, but not 
statistically significant.  
The liver injury is often mediated by free 
radicals or by the depletion of endogenous pool of 
antioxidants such as GSH. Many authors reported 
that reduced glutathione (GSH) plays a vital role in 
cellular function. GSH effectively scavenges free 
radicals and other reactive oxygen species (e.g. 
hydroxyl radical, lipid peroxyl radical, peroxynitrite 
and H2O2) directly and indirectly through enzymatic 
reactions (33). In such reactions, GSH is oxidized to 
form GSSG, which is then reduced to GSH by the 
NADPH-dependant glutathione reductase. In 
addition, glutathione peroxidase (a selenium-
containing enzyme) catalyzes the GSH-dependant 
reduction of H2O2 and other peroxides and protects 
the organism from oxidative damage. Glutathione 
detoxifies toxic metabolites of drugs, regulates gene 
expression, apoptosis and transmembrane transport 
of organic solutes. It is essential to maintain the 
reduced status of the cell/tissue (34), and its severe 
depletion is reported to lead to liver injury (35).  
We obtained significant depletion of GSH 
level in the liver after injection of both hepatotoxins 
comparing to normal control rats. This result 
supports the view that oxidative stress takes place 
extensively in the liver during necrosis. The oral 
administration of the ST and TPA prior to the 
induction of liver necrosis resulted in increase of 
the hepatocyte GSH (Figure 3 c.). Inhibition of XO 
and reduction of ROS in ST and TPA pretreatment 
led to elevation of GSH because the pool of this 
antioxidant in the liver remained unused. This could 
provide an explanation for the manifold increasing 
in hepatic GSH content in the rats which were 
pretreated with tungstate compounds followed by J Pharm Pharmaceut Sci (www. cspsCanada.org) 10 (3): 340-349, 2007 
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hepatotoxins. Interestingly, ST compound was more 
potent in increasing GSH concentration in CCl4 
induced hepatic injury, which could explain better 
the protective effect of this tungstate compound in 
CCl4 induced hepatic injury (Figure 3 d). In TAA 
induced hepatic injury, TPA was more efficient in 
increasing GSH which could explain improvement 
in histological and biochemical parameters of liver 
necrosis.   
In conclusion, the present findings suggest 
that tungstophosphoric acid, as well as sodium 
tungstate, have protective effects on chemically 
induced liver necrosis which could be explained by 
their antioxidant properties. Therefore, further work 
is needed to investigate usefulness of these 
inorganic compounds in the prevention of 
chemically induced hepatic injury.   
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